Role of cetuximab in the treatment of patients with NSCLC: are we throwing out the baby with the bath water?

J Clin Oncol. 2010 Sep 20;28(27):e467; author reply e468. doi: 10.1200/JCO.2010.28.5973. Epub 2010 Jun 28.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / genetics
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Cetuximab
  • Evidence-Based Medicine
  • Genetic Markers
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Patient Selection
  • Predictive Value of Tests
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Genetic Markers
  • Cetuximab